tarsatherapeutics.com
1628 John F. Kennedy Boulevard 8 Penn Center Suite 1400 Philadelphia, Pennsylvania 19103, US
Tarsa Therapeutics, Inc
Tarsa Therapeutics developed TBRIA™, an oral formulation of calcitonin for postmenopausal osteoporosis treatment. TBRIA demonstrated safety and efficacy in a Phase 3 trial, showing superiority over placebo and nasal calcitonin spray in increasing bone mineral density. R-Pharm JSC acquired rights to TBRIA for further clinical development and regulatory submissions. Tarsa Therapeutics focuses on developing innovative oral treatments for osteoporosis, specifically targeting women post-menopause when other treatments are not suitable.
Tarsa Therapeutics, Inc
Tarsa Therapeutics developed TBRIA™, an oral formulation of calcitonin for postmenopausal osteoporosis treatment. TBRIA demonstrated safety and efficacy in a Phase 3 trial, showing superiority over placebo and nasal calcitonin spray in increasing bone mineral density. R-Pharm JSC acquired rights to TBRIA for further clinical development and regulatory submissions. Tarsa Therapeutics focuses on developing innovative oral treatments for osteoporosis, specifically targeting women post-menopause when other treatments are not suitable.
tarsatherapeutics.com
1628 John F. Kennedy Boulevard 8 Penn Center Suite 1400 Philadelphia, Pennsylvania 19103, US
Details
Year founded
N/A
Revenue
5M-10M
Employees
11-50
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Capsules
- TBRIA™ Oral Calcitonin
- Tablets
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Manufacturing Line for TBRIA™ Oral Formulation
- Calcitonin Treatment Production Equipment
- Postmenopausal Osteoporosis Treatment Machinery
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that tarsa therapeutics is not ramping up production.
Target industries
Locations (1)
Tarsa Therapeutics, Inc
1628 John F. Kennedy Boulevard 8 Penn Center Suite 1400 Philadelphia, Pennsylvania 19103, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Tarsa Therapeutics, Inc offer?
Tarsa Therapeutics, Inc offers a range of services and capabilities, including Capsules.
What kind of equipment does Tarsa Therapeutics, Inc use?
Tarsa Therapeutics, Inc uses a variety of equipment, including Manufacturing Line for TBRIA™ Oral Formulation.
What are the target industries of Tarsa Therapeutics, Inc?
Tarsa Therapeutics, Inc serves several industries, including the medical industry.
How many locations does Tarsa Therapeutics, Inc operate?
Tarsa Therapeutics, Inc operates from a single location at 8 penn center suite 1400, philadelphia, pennsylvania 19103, united states.
Where are the headquarters of Tarsa Therapeutics, Inc?
The headquarters of Tarsa Therapeutics, Inc are located in 8 penn center suite 1400, philadelphia, pennsylvania 19103, united states.
What is the NAICS code for Tarsa Therapeutics, Inc?
The NAICS code for Tarsa Therapeutics, Inc is 3254.
How many employees does Tarsa Therapeutics, Inc have?
Tarsa Therapeutics, Inc has 13 employees.
What is the official website of Tarsa Therapeutics, Inc?
The official website of Tarsa Therapeutics, Inc is https://tarsatherapeutics.com/.